IRMAA raises Medicare Part B and Part D premiums for higher-income retirees. Learn how IRMAA is calculated, income limits, and how appeals can reduce costs.
A 10% jump in insurance premiums impacts the 2.8% Social Security cost‑of‑living adjustment — and a new IRS requirement ...
At Home Hustle on MSN
The Medicare Part B mistake: The single form you must file at 65 to avoid lifetime penalties
Turning 65 should feel liberating, a milestone marking decades of hard work finally rewarded with Medicare coverage. Yet for hundreds of thousands of Americans, that birthday becomes the start of a ...
Toni: I have been reading your Medicare column, and now I need your Medicare help. I am retiring when I turn 65 in April. I was hospitalized in November of 2025 with a triple bypass surgery.
A smaller026 Social Security check is often due to COLA limits, Medicare premiums, taxes, or earnings rules. Here's what may ...
The Orphan Drug Act revolutionized rare disease treatment, yet rising costs and access issues challenge equitable health care solutions.
In an advisory opinion published at the end of 2025, the U.S. Department of Health and Human Services Office of Inspector General (OIG) addressed—to ...
Islands.com on MSN
5 Reasons Portugal Is Such A Popular European Retirement Destination
From coastal towns to historic cities, Portugal has become a top choice for retirees seeking an easier pace of life, ...
The combination of GENEROUS for Medicaid, Globe for Medicare Part B and Guard for Medicare Part D will heavily impact the US drug market. President Trump’s rhetoric has been that other countries ...
While healthcare-related False Claims Act actions generated over $5.7 billion of the record $6.8 billion in fiscal 2025 ...
The Trump administration finalized a new policy on Thursday giving the president the power to fire or discipline as many as 50,000 career federal employees, the latest step in the president’s efforts ...
Over the past four decades, rare disease drug development has evolved from a scientific aspiration into a central pillar of biopharmaceutical innovation. Regulatory reforms, scientific breakthroughs, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results